Authors: MARSHALL JL WELLSTEIN A RAE J DELAP RJ PHIPPS K HANFELT J YUNMBAM MK SUN JX DUCHIN KL HAWKINS MJ

Citation: Jl. Marshall et al., PHASE-I TRIAL OF ORALLY-ADMINISTERED PENTOSAN POLYSULFATE IN PATIENTSWITH ADVANCED CANCER, Clinical cancer research, 3(12), 1997, pp. 2347-2354

Authors: DELAP RJ

Citation: Rj. Delap, OBSTACLES AT THE FDA, Scientific American, 276(1), 1997, pp. 8-8

Authors: MARSHALL JL RICHMOND E DELAP RJ

Citation: Jl. Marshall et al., BIOCHEMICAL MODULATION IN THE TREATMENT OF ADVANCED CANCER - A STUDY OF COMBINED LEUCOVORIN, FLUOROURACIL, AND IODODEOXYURIDINE, Clinical cancer research, 2(9), 1996, pp. 1475-1480

Authors: MARSHALL JL DELAP RJ

Citation: Jl. Marshall et Rj. Delap, CLINICAL PHARMACOKINETICS AND PHARMACOLOGY OF TRIMETREXATE, Clinical pharmacokinetics, 26(3), 1994, pp. 190-200

Authors: BACHMAN WJ DELAP RJ

Citation: Wj. Bachman et Rj. Delap, POPULATION PHARMACOKINETICS OF HIGH-DOSE ZIDOVUDINE IN A PHASE-I CANCER STUDY, Drug investigation, 8(3), 1994, pp. 134-142

Authors: MARSHALL JL DELAP RJ

Citation: Jl. Marshall et Rj. Delap, AN ALTERNATE METHOD TO OVERCOMING CENTRAL VENOUS CATHETER BLOCKAGE INPATIENTS RECEIVING HIGH-DOSE FLUOROURACIL AND LEUCOVORIN, Journal of clinical oncology, 11(7), 1993, pp. 1433-1434